Study: NCT04905914

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRN-119
Description: ATRN-119 is a capsule formulation that will be supplied as 50 mg and 100 mg capsules packed in sealed plastic bottles (n=30) and dispensed by the site pharmacist in combinations to provide the appropriate dose.